BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7908537)

  • 1. Neurotransmitter replacement therapy in Alzheimer's disease.
    Mohr E; Mendis T; Rusk IN; Grimes JD
    J Psychiatry Neurosci; 1994 Jan; 19(1):17-23. PubMed ID: 7908537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurotransmitters in Alzheimer's disease].
    Kristensen MO
    Ugeskr Laeger; 1990 Jul; 152(30):2165-8. PubMed ID: 1975961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurotransmitters in Alzheimer's disease].
    Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
    Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGF and the treatment of Alzheimer's disease.
    Olson L
    Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of memantine on the levels of glial cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of ibotenic acid-treated alzheimer's disease model.
    Ahmed MM; Hoshino H; Chikuma T; Yamada M; Kato T
    Neuroscience; 2004; 126(3):639-49. PubMed ID: 15183513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Relkin NR
    Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease.
    Michelsen KA; Prickaerts J; Steinbusch HW
    Prog Brain Res; 2008; 172():233-64. PubMed ID: 18772036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory functioning in Alzheimer's disease.
    Amieva H; Phillips LH; Della Sala S; Henry JD
    Brain; 2004 May; 127(Pt 5):949-64. PubMed ID: 14645147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic and glutamatergic drugs in Alzheimer's disease therapy.
    Clarke NA; Francis PT
    Expert Rev Neurother; 2005 Sep; 5(5):671-82. PubMed ID: 16162091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurochemistry of Alzheimer's disease.
    Engelborghs S; De Deyn PP
    Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological basis of drug therapy of Alzheimer's disease.
    Sharma A; Parikh V; Singh M
    Indian J Exp Biol; 1997 Nov; 35(11):1146-55. PubMed ID: 9567741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and the pivotal role of the hypothalamus and the intrinsic opioid system.
    Iacono RP; Sandyk R
    Int J Neurosci; 1987 Feb; 32(3-4):710-4. PubMed ID: 3036727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic changes in Alzheimer's disease.
    Wenk GL
    J Clin Psychiatry; 2003; 64 Suppl 9():7-10. PubMed ID: 12934968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.